Medicenna Therapeutics Corp (MDNAF)

OTC Markets
Currency in USD
0.8000
+0.0402(+5.29%)
Closed·
MDNAF Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MDNAF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.75010.8200
52 wk Range
0.60002.1740
Key Statistics
Edit
Prev. Close
0.7598
Open
0.779
Day's Range
0.7501-0.82
52 wk Range
0.6-2.174
Volume
65.82K
Average Vol. (3m)
55.77K
1-Year Change
-54.02%
Book Value / Share
0.16
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDNAF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Medicenna Therapeutics Corp Company Profile

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops bizaxofusp (MDNA55), an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a masked bi-functional anti-PD1-IL2 Superkine for various solid tumors; and MDNA132, an IL-13 Superkine for various tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, inhibitors, antibodies, cytokines, or other Superkines Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Compare MDNAF to Peers and Sector

Metrics to compare
MDNAF
Peers
Sector
Relationship
P/E Ratio
−3.5x−2.6x−0.5x
PEG Ratio
0.060.080.00
Price / Book
5.4x1.0x2.6x
Price / LTM Sales
-2.1x2.9x
Upside (Analyst Target)
-170.6%49.4%
Fair Value Upside
Unlock6.4%8.2%Unlock

Earnings

Latest Release
Feb 13, 2025
EPS / Forecast
-0.0492 / -0.0476
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Medicenna Therapeutics Corp (MDNAF) Stock Price Today?

The Medicenna Therapeutics Corp stock price today is 0.80

What Stock Exchange Does Medicenna Therapeutics Corp Trade On?

Medicenna Therapeutics Corp is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Medicenna Therapeutics Corp?

The stock symbol for Medicenna Therapeutics Corp is "MDNAF."

What Is the Medicenna Therapeutics Corp Market Cap?

As of today, Medicenna Therapeutics Corp market cap is 67.47M.

What Is Medicenna Therapeutics Corp's Earnings Per Share (TTM)?

The Medicenna Therapeutics Corp EPS (TTM) is -0.36.

When Is the Next Medicenna Therapeutics Corp Earnings Date?

Medicenna Therapeutics Corp will release its next earnings report on Jun 25, 2025.

From a Technical Analysis Perspective, Is MDNAF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.